Actyus Private Equity SGIIC, S.A. 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-07 11:58 am Sale | 2025-09-30 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 268,564 1.600% | -587,818 (-68.64%) | Filing |
| 2025-05-14 09:26 am Purchase | 2025-03-31 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 856,382 5.400% | 268,564 (+45.69%) | Filing |
| 2025-01-07 4:30 pm Purchase | 2023-12-08 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 587,818 5.450% | 587,818 (New Position) | Filing |